About: http://data.cimple.eu/news-article/ce4c9155463fbe7634df70161942cb87268e420249009c091ee447ed

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/ce4c9155463fbe7634df70161942cb87268e420249009c091ee447ed Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	Three of the four authors behind a large-scale study in The Lancet that raised safety fears over the use of common anti-malarial drugs to treat COVID-19 retracted their paper on Thursday, blaming a health care company that supplied the dataset. The study retrospectively analyzed some 96,000 patient records, finding that hydroxychloroquine and chloroquine showed no benefit against the coronavirus and even increased the risk of dying in hospital, with heart arrhythmia a particular concern. The finding led the World Health Organization to suspend clinical trials into the medicines, but it was soon followed by widespread concern among scientists over a lack of information about the countries and hospitals that contributed data. Mandeep Mehra, a professor at Harvard University who led the work, along with Frank Ruschitzka of the University Hospital Zurich and Amit Patel of the University of Utah, said in a statement they had tried to launch a third-party peer review into the data. But Surgisphere, a little-known health care analytics firm based in Chicago that supplied the records, refused to cooperate with the peer reviewers, who had been asked to verify the records and replicate the study's findings. "Based on this development, we can no longer vouch for the veracity of the primary data sources," the three said. "Due to this unfortunate development, the authors request that the paper be retracted." They stressed that they had worked "in good faith and at a time of great need during the COVID-19 pandemic. "We deeply apologize to you, the editors, and the journal readership for any embarrassment or inconvenience that this may have caused." Sapan Desai, a vascular surgeon and Surgisphere's chief executive, did not join the retraction. The public relations firm that represents him told AFP he would not be making a comment at this time. ia/bgs
schema:headline	Authors pull study flagging hydroxychloroquine risks
schema:mentions	Public relations University of Chicago Heart arrhythmia Agence France-Presse Chloroquine The Lancet Ia (cuneiform) Hydroxychloroquine Harvard University World Health Organization Pandemic Severe acute respiratory syndrome coronavirus 2 Health care analytics Amit Patel Vascular surgery University of Utah University Hospital of Zürich Rakeysh Omprakash Mehra
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2020-06-04 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	negative sentiment
http://data.cimple...readability_score	86 (xsd:integer)
http://data.cimple...entionsConspiracy	suppressed cures conspiracy theory

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 5 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software